Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChaiwat Teekhasaeneeen_US
dc.contributor.authorRobert Ritchen_US
dc.contributor.authorUthai Rutninen_US
dc.contributor.authorNisit Leelawongsen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNew York Eye and Ear Infirmaryen_US
dc.contributor.otherRutnin Hospitalen_US
dc.contributor.otherSaint Louise Hospitalen_US
dc.identifier.citationArchives of Ophthalmology. Vol.108, No.8 (1990), 1114-1120en_US
dc.description.abstractWe examined 194 patients with oculodermal melanocytosis. Dermal involvement alone was present in 67 (34.5%) patients, while 12 (6.2%) had only ocular involvement. The remaining 115 (59.3%) patients had both ocular and dermal pigmentation. Dermal hyperpigmentation in the combined distribution of the ophthalmic and maxillary divisions of the trigeminal nerve and hyperpigmentation of the nasal or buccal mucosa were closely associated with ocular involvement. Ocular hyperpigmentation most commonly involved the episclera. Associated ocular findings included elevated intraocular pressure with or without glaucoma (10.3%), uveitis (2.6%), cataract (1%), asymmetric cupping of the optic nerve head unassociated with glaucoma (9.8%), and orbital melanoma (0.5%). The most serious complication of oculodermal melanocytosis is malignant transformation, while glaucoma appears to be the more common one. Patients with oculodermal melanocytosis and ocular hyperpigmentation should be followed up at regular intervals for the development of either of these complications. © 1990, American Medical Association. All rights reserved.en_US
dc.rightsMahidol Universityen_US
dc.titleOcular Findings in Oculodermal Melanocytosisen_US
Appears in Collections:Scopus 1969-1990

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.